Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Symeou Dental Center, a well-established dental clinic based in the heart of Nicosia, has announced the expansion of its ...

About IMNN-001 Immunotherapy Designed using IMUNON's proprietary TheraPlas® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables ...

The company has established an integrated R&D platform encompassing sequence design, chemical modification, and drug delivery ... selected-for-ats-2025-oral-presentation-demonstrating-world ...

TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation ... and ...

About IMNN-001 Immunotherapy Designed using IMUNON's proprietary TheraPlas ® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell ...

Results are being highlighted in an oral presentation at the 2025 American ... an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell transfection followed by ...

Alarum Technologies Ltd. ( NASDAQ: ALAR) Q1 2025 Earnings Conference Call May 29, 2025 8:30 AM ET Brian Kinstlinger - Alliance Global Partners Kingsley Crane - Canaccord Genuity ...

NanoViricides, Inc. (NYSE American: NNVC) announced it will present at the BIO International Convention 2025 in Boston on Monday, June 16 at 2:30 p.m ...